185 related articles for article (PubMed ID: 21896849)
1. Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy.
Kalirai H; Damato BE; Coupland SE
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8458-66. PubMed ID: 21896849
[TBL] [Abstract][Full Text] [Related]
2. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells.
Li H; Chen X; Calhoun-Davis T; Claypool K; Tang DG
Cancer Res; 2008 Mar; 68(6):1820-5. PubMed ID: 18339862
[TBL] [Abstract][Full Text] [Related]
3. CD166high Uveal Melanoma Cells Represent a Subpopulation With Enhanced Migratory Capacity.
Djirackor L; Kalirai H; Coupland SE; Petrovski G
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2696-2704. PubMed ID: 31242292
[TBL] [Abstract][Full Text] [Related]
4. The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines.
Mo J; Sun B; Zhao X; Gu Q; Dong X; Liu Z; Ma Y; Zhao N; Liu Y; Chi J; Sun R
Melanoma Res; 2013 Aug; 23(4):254-63. PubMed ID: 23752306
[TBL] [Abstract][Full Text] [Related]
5. Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
Chandrasekaran S; DeLouise LA
Biomaterials; 2011 Dec; 32(35):9316-27. PubMed ID: 21917310
[TBL] [Abstract][Full Text] [Related]
6. Sphere formation and self-renewal capacity of melanoma cells is affected by the microenvironment.
Sztiller-Sikorska M; Koprowska K; Jakubowska J; Zalesna I; Stasiak M; Duechler M; Czyz ME
Melanoma Res; 2012 Jun; 22(3):215-24. PubMed ID: 22495670
[TBL] [Abstract][Full Text] [Related]
7. A tumorigenic subpopulation with stem cell properties in melanomas.
Fang D; Nguyen TK; Leishear K; Finko R; Kulp AN; Hotz S; Van Belle PA; Xu X; Elder DE; Herlyn M
Cancer Res; 2005 Oct; 65(20):9328-37. PubMed ID: 16230395
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA polymorphisms and biogenesis genes in primary and metastatic uveal melanoma cell lines.
Singh L; Atilano SR; Jager MJ; Kenney MC
Cancer Genet; 2021 Aug; 256-257():91-99. PubMed ID: 34082186
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic Plasticity in Uveal Melanoma Is Not Restricted to a Tumor Subpopulation and Is Unrelated to Cancer Stem Cell Characteristics.
Doherty RE; Sisley K; Hammond DW; Rennie IG; Cross NA
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5387-5395. PubMed ID: 29049740
[TBL] [Abstract][Full Text] [Related]
10. Trastuzumab (herceptin) targets gastric cancer stem cells characterized by CD90 phenotype.
Jiang J; Zhang Y; Chuai S; Wang Z; Zheng D; Xu F; Zhang Y; Li C; Liang Y; Chen Z
Oncogene; 2012 Feb; 31(6):671-82. PubMed ID: 21743497
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
12. c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential.
Wu X; Zhou J; Rogers AM; Jänne PA; Benedettini E; Loda M; Hodi FS
Melanoma Res; 2012 Apr; 22(2):123-32. PubMed ID: 22343486
[TBL] [Abstract][Full Text] [Related]
13. Modeling of human uveal melanoma in zebrafish xenograft embryos.
van der Ent W; Burrello C; Teunisse AF; Ksander BR; van der Velden PA; Jager MJ; Jochemsen AG; Snaar-Jagalska BE
Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6612-22. PubMed ID: 25249605
[TBL] [Abstract][Full Text] [Related]
14. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.
All-Ericsson C; Girnita L; Seregard S; Bartolazzi A; Jager MJ; Larsson O
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):1-8. PubMed ID: 11773005
[TBL] [Abstract][Full Text] [Related]
16. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the involvement of the nuclear factor-kappa B (NF kappa B) transcription factor in uveal melanoma.
Dror R; Lederman M; Umezawa K; Barak V; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):1811-6. PubMed ID: 19892878
[TBL] [Abstract][Full Text] [Related]
18. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers.
Hendrix MJ; Seftor EA; Seftor RE; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Lab Invest; 1998 Feb; 78(2):153-63. PubMed ID: 9484713
[TBL] [Abstract][Full Text] [Related]
19. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
20. The role of RASSF1A in uveal melanoma.
Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
